IP consultant and patent advocate extraordinaire Greg Aharonian has presented a lawsuit to attempt to get a court to determine that copyright doesn’t protect software adequately and that patents are sufficient protection. Aharonian edits the popular and interesting site Patenting Read more…
The new issue of SCRIPTed is now online. This issue covers a good range of issues, including an analysis of the German case that has declared the validity of the GPL.
This is where the great battle of our time will be fought. The P2P debate in the US Supreme Court is upon us, a case that will probably shape the near future of the legal validity of sharing networks. But Read more…
Some local news from Costa Rica. The weirdest patent claim has made some of the news over here, after a Canadian patented and claimed the ownership of the “canopy tours”, a great way to travel on the top of the Read more…
This is a great article by Fred von Lohmann about the surreal case of Marvel suing the makers of the popular “City of Heroes” MMORPG game. Marvel complains that City of Heroes is guilty of contributory infringement of copyright and Read more…
This is an excellent article by Regina Lynn about the dangers of Google and leaving a digital trail. We are increasingly leaving a digital footprint that tells people about our interests, opinions and tastes. People can Google and find some Read more…
Reuters reports that Microsoft is targetting its cheap (sorry, “low cost”) version of Windows XP to Asian markets. The stated purpose of this is to try to make Windows more appealing in emerging markets. The real reasons are: to hook Read more…
Technollama is coming to you today from the Playfair Library, where we are attending the very interesting conference named “Towards Utopia or Irreconcilable Tensions: the interface between intellectual property, competition and human rights“. More reports later, but I am hoping Read more…
This is an interesting article in the excellent WorldChanging blog. The article looks at the possibility of using open source models in drugs and biotechnology. Although the article cites many of the possible uses for the technology, it fails to Read more…